vimarsana.com

Page 15 - எலும்பியல் மருத்துவ பரிசோதனை News Today : Breaking News, Live Updates & Top Stories | Vimarsana

In Vitro Diagnostics (IVD) Market Size, Growth Trends, Top Players, Application Potential and Forec

In Vitro Diagnostics (IVD) Market Size, Growth Trends, Top Players, Application Potential and Forec
pharmiweb.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from pharmiweb.com Daily Mail and Mail on Sunday newspapers.

Ortho signs $53 7M government contract to triple its COVID-19 test production

Apr 5, 2021 11:43am Backed by BARDA and the Department of Defense, Ortho Clinical Diagnostics is planning to provide up to 6.7 million COVID tests per month by April 2022. (Getty Images)(Circle Creative Studio/iStock/Getty Images Plus/Getty Images) Vaccination rates may be steadily climbing across the country, but companies hope COVID-19 testing won t slow down any time soon. In fact, manufacturers are now ramping up production of antigen and antibody tests, with Ortho Clinical Diagnostics, for one, expecting to triple its output within the next year. Ortho’s increased production will be backed by a new contract with the U.S. government s Biomedical Advanced Research and Development Authority, known as BARDA, and a COVID-19 acquisition task force set up by the Air Force.

Ortho Announces Plans to Accelerate COVID-19 Antigen and Antibody Test Development Through New Contract with BARDA and the Department of Defense

Share this article - The new contract will deliver Ortho with funding for capacity expansion to provide up to 6.7 million COVID-19 tests per month dedicated for the U.S. market over the next 12-14 months  RARITAN, N.J., March 31, 2021 /PRNewswire/ Ortho Clinical Diagnostics (Nasdaq: OCDX), one of the world s largest pure-play IVD companies, today announced that through its continued partnership with the Biomedical Advanced Research and Development Authority (BARDA) and the U.S. Department of Defense, the company been awarded an undefinitized contract which will lead to a $53.7 million contract that will support a more than three-fold increase in domestic production capabilities for its COVID-19 serological and diagnostic testing solutions.

Abbott Laboratories (NYSE:ABT), (AMTI) - The Daily Biotech Pulse: Pfizer-BioNTech Preps For BLA Filing, Sonoma Surges, BioXcel Readout, Ortho Clinical Lands Contract

Abbott Laboratories (NYSE:ABT), (AMTI) - The Daily Biotech Pulse: Pfizer-BioNTech Preps For BLA Filing, Sonoma Surges, BioXcel Readout, Ortho Clinical Lands Contract
benzinga.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from benzinga.com Daily Mail and Mail on Sunday newspapers.

Ortho s VITROS® SARS-CoV-2 Antigen Test for High-Volume Testing Receives FDA Emergency Use Authorization for New Performance, Sensitivity Data

Ortho s VITROS® SARS-CoV-2 Antigen Test for High-Volume Testing Receives FDA Emergency Use Authorization for New Performance, Sensitivity Data
prnewswire.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from prnewswire.com Daily Mail and Mail on Sunday newspapers.

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.